- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03904706
Linking Facility-based Mortality Audits With Community Engagement in Gilgit-Baltistan, Pakistan
A Pilot Study: Linking Facility-based Mortality Audits With Community Engagement to Improve Maternal and Newborn Outcomes in Gilgit-Baltistan, Pakistan
Pakistan is one of the countries in South Asia where neonatal mortality rates remain stagnant. Babies born in Pakistan encounter the highest risk of dying; of every 1,000 babies born, 46 die before the end of their first month (UNICEF, 2018). Some of the highest perinatal and neonatal mortality rates in Pakistan are found in districts of Pakistan's mountainous northern region (Bhutta ZA, 2013), where geography, climate and security risks make it challenging for women in remote communities to reach health services in a timely manner. According to 2013 PDHS, the neonatal and perinatal mortality rate in the northern area of Gilgit Baltistan was 39/1,000 and 37/1,000, respectively. In the rural area of Khyber Pakhtunkhwa, the neonatal and perinatal mortality rate was 42/1,000 and 63/1,000, respectively.
Implementation of a health facility mortality audit cycle has proved successful in reducing perinatal mortality by upto 30% in other LMICs. Meanwhile evidence suggests that the most common factors contributing to high mortality rates are due to phase-one delays (delay in the decision to seek care). This study will attempt to operationalize linkages between the community and facility to not only improve facility-based quality of care, but to bring change in the community through community-feedback meetings to mitigate phase one and two delays and improve maternal, perinatal and neonatal outcomes. Data from this study will inform MoH policy decisions about standardized mortality audits with community feedback.
Given the geographical location of Gilgit-Baltistan (GB) and accompanying constraints such as terrain and security, this study will attempt to operationalize linkages between the community and facility to not only improve facility-based quality of care, but to bring change in the community through community-feedback meetings to mitigate phase one and two delays and improve maternal, perinatal and neonatal outcomes. Data from this study will inform MoH policy decisions about standardized mortality audits with community feedback.
Study Overview
Status
Intervention / Treatment
Detailed Description
Pakistan has the highest global newborn mortality rate (45.6/1,000 live births), with 1 in 22 babies dying before the end of their first month (UNICEF, 2018). Some of the highest perinatal and neonatal mortality rates are found in districts of Pakistan's mountainous northern region, where geography, climate and security risks make it challenging for women in remote communities to reach health services in a timely manner. Implementation of a health facility mortality audit cycle has proved successful in reducing perinatal mortality by up to 30% in other LMICs. Meanwhile evidence suggests that the most common factors contributing to high mortality rates are due to phase-one delays. Given the geographical location of GB and accompanying constraints such as terrain and security, this study will attempt to operationalize linkages between the community and facility to not only improve facility-based delivery services, but to effect change at the community, through community-feedback meetings to mitigate phase one and two delays and improve maternal, perinatal and neonatal outcomes. Data from this study may help inform government policy decisions about standardized mortality audits with community feedback.
Objectives of the study
Broad objective:
The overall aim of the study is to assess whether implementation of facility-based maternal, perinatal and neonatal mortality audits (systemic clinical reviews of near misses and deaths), in combination with targeted community engagement and awareness activities, increases the recognition of danger signs during pregnancy, the number of facility deliveries and encourages the discussion of a birthing plan, thereby reducing phase -one, two and three delays as compared to implementing facility-based mortality audits only. This will be assessed by monitoring births and outcomes in public and private health facilities and their associated catchment communities in GB. The study will also evaluate whether these targeted community-engagement activities, informed by the clinical audits improve the quality of delivery services through better utilization of local resources and improvements in clinical signal functions.
Specific objectives Primary objective
To determine the effect of a combined approach of facility-based audits (clinical reviews) linked to community engagement on core community behaviours/practices to improve obstetric, perinatal and neonatal outcomes as compared to standard perinatal and neonatal facility-based audits only and no facility-based audits. Key practices include:
- Recognition of danger signs among women during pregnancy, labour and delivery, after delivery and in newborns
- Actions taken for a birthing preparation plan
Secondary objectives
- Assess facility deliveries
- Assess severe maternal morbidity outcomes during delivery (including maternal near misses )
- Assess changes in quality of delivery services as measured through the delivery room checklist
- Assess changes in first delay (care-seeking decision) I. Delay due to lack of knowledge II. Lack of empowerment (sociocultural factors/barriers such as women's decision making, women's status)
- Assess changes in second delay (identification and reaching health facility)
- Assess changes in third delay (receiving adequate care and treatment at facilities)
- Assess perinatal mortality rates (fresh still birth or neonatal death in the first week of life)
- Assess neonatal mortality rates (deaths in the first 28 days of life)
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Gilgit-Baltistan
-
Gilgit, Astore, Ghizer, Hunza And Nagar, Gilgit-Baltistan, Pakistan, 74800
- Government and AKHSP Health Facilities in Gilgit-Baltistan
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Women aged 15-49 years who have had a pregnancy in the last 12 months who reside in the five targeted districts. Public and private health facilities in five districts in GB that offer obstetric and postnatal care, and respective catchment areas are supported by LHWs, Lady Health Volunteers (LHVs), CMWs, and CHWs will be included in the study. Data for all maternal 'near misses', perinatal and neonatal mortality and morbidity outcomes will be recorded for all women and newborns who deliver at home (through LHW, LHV, CMW monthly reports) and who contact the health facility within 42 days post-delivery, regardless of whether or not they delivered in the health facility.
Exclusion Criteria:
- Women aged 15-49 years who have not had a pregnancy in the last 12 months, who reside in the five targeted districts. Health facilities in five districts of GB that do not provide any obstetric and postnatal care and are not affiliated with any LHWs, or CMWs will be excluded.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Audits only
Formalized audit teams with monthly meetings at each facility. Audit Intervention phases:
|
Formalized audit teams with monthly meetings at each facility.
|
|
Experimental: Audits with community feedback
This intervention will implement the audits as described in arm 1; however, key community representatives (approximately 3-5 members) will be identified to attend monthly follow-up meetings with audit team leaders to discuss the community aspects (phase one and two-delays) that could have prevented the death, near miss or severe adverse outcome.
Information regarding the cause(s) of death in the community will be collected by the LHW or CMW, who reports to the health facility on a monthly basis.
|
This intervention will implement the audits as described in arm 1; however, key community representatives (approximately 3-5 members) will be identified to attend monthly follow-up meetings with audit team leaders to discuss the community aspects (phase one and two-delays) that could have prevented the death, near miss or severe adverse outcome.
Information regarding the cause(s) of death in the community will be collected by the LHW or CMW, who reports to the health facility on a monthly basis.
|
|
No Intervention: Control
Monthly outcome data will be collected from health facilities where no audits will be conducted.
Data from this group will help evaluate the effectiveness of the intervention arms on perinatal and neonatal mortality.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in proportion of women who can correctly identify at least 3 danger signs at each stage across the continuum of care
Time Frame: 12 months
|
Change in proportion of women who can correctly identify at least 3 danger signs at each stage across the continuum of care
|
12 months
|
|
Change in proportion of women for which at least 5 birthing plan actions were taken for the birth of the index child
Time Frame: 12 months
|
Change in proportion of women for which at least 5 birthing plan actions were taken for the birth of the index child: Discussed place of delivery, Discussed who will perform delivery, Set aside funds for delivery, Set aside alternate funds for costs of skilled and emergency care, Made arrangements for transport, Identified a blood donor, Discussed accompaniment to planned delivery location.
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in number of facility deliveries
Time Frame: 12 months
|
Change in number of facility deliveries (including number of postnatal visits).
|
12 months
|
|
Change in severe maternal morbidity outcomes
Time Frame: 12 months
|
Change in severe maternal morbidity outcomes: proportion of assisted deliveries, emergency caesarean sections, transfusions and hysterectomies.
|
12 months
|
|
Change in the quality of delivery services
Time Frame: 12 months
|
Change in the quality of delivery services as measured through the delivery room checklist
|
12 months
|
|
Change in proportion of first, second and third delays
Time Frame: 12 months
|
Change in proportion of first, second and third delays
|
12 months
|
|
Perinatal mortality (fresh stillbirth or neonatal death in the first week of life)
Time Frame: 12 months
|
Perinatal mortality (fresh stillbirth or neonatal death in the first week of life)
|
12 months
|
|
Neonatal mortality (deaths in the first 28 days of life)
Time Frame: 12 months
|
Neonatal mortality (deaths in the first 28 days of life)
|
12 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Sajid Soofi, FCPS, MBBS, Aga Khan University
- Principal Investigator: Diego Bassani, PhD, Centre for Global Child Health, SickKids Research Institute - Toronto, Canada
- Principal Investigator: Aminah Jahangir, MBBS, HPM, Aga Khan Foundation, Pakistan
- Principal Investigator: Zulfiqar A Bhutta, PhD, Centre for Global Child Health, SickKids Research Institute - Toronto, Canada
- Principal Investigator: Gul Nawaz Khan, MA, MPH, Aga Khan University
- Principal Investigator: Suzanne E Powell, MSc, Centre for Global Child Health, SickKids Research Institute - Toronto, Canada
- Principal Investigator: Miraj Uddin, MA, Aga Khan Health Services
- Principal Investigator: Saad Y Sulaimani, MSc, Aga Khan Foundation, Pakistan
- Principal Investigator: Asma Sittar, MSc, Aga Khan Development Network - Islamabad, Pakistan
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- GB mortality audits study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on External Causes of Morbidity and Mortality
-
Pontificia Universidad Catolica de ChileCompletedExternal Causes of Morbidity and Mortality | External Causes of Morbidity (V00-Y99)
-
Genton Graf LaurenceCompletedExternal Causes of Morbidity and MortalitySwitzerland
-
Loyola UniversityCompletedExternal Causes of Morbidity and MortalityUnited States
-
Tata Main HospitalCompleted
-
Bakirkoy Dr. Sadi Konuk Research and Training HospitalUnknownExternal Causes of Morbidity and Mortality | Complications; Cesarean Section | Failure of Cervical Dilatation | Wound Infection,Turkey
-
Ruhr University of BochumCompletedExternal Causes of Morbidity and MortalityGermany
-
Prince of Songkla UniversityTerminatedHypoglycemia | Nosocomial Infection | External Causes of Morbidity and MortalityThailand
-
Azienda Ospedaliero Universitaria Maggiore della...UnknownMyocardial Infarction | External Causes of Morbidity and Mortality | Fracture of Stent of Coronary Artery | Coronary Vessel DisordersItaly
-
Royal College of Anesthesiologists of ThailandChulalongkorn University; Khon Kaen University; Ramathibodi Hospital; Prince of... and other collaboratorsCompletedCritical Illness | Complications of Surgical and Medical Care: General Terms | Adverse Reaction to Drug | Sequelae of External Causes of Morbidity and MortalityThailand
-
West China HospitalUnknownQuality of Life | Gastric Cancer | Surgery | Blood Loss, Surgical | External Causes of Morbidity and Mortality | Ultrasonic Scalpel | Monopolar Electrocautery | Operation TimeChina
Clinical Trials on Audits only
-
The Hospital for Sick ChildrenUniversity of the Sciences, Techniques and Technologies of Bamako; Global Affairs... and other collaboratorsCompleted
-
Orthopaedic Research FoundationCompletedArthritis | Knee OsteoarthritisUnited States
-
George Washington UniversityCity University of New YorkCompletedOverweight and Obesity
-
Florida State UniversityCompleted
-
Purdue UniversityRecruitingHealthy VolunteersUnited States
-
Florida State UniversityCompleted
-
Centre Leon BerardInstitut d'Hématologie et d'Oncologie Pédiatrique; Fondation La Roche PosayNot yet recruitingAcute Lymphoblastic Leukemia, Pediatric
-
Freedom Laser, Inc.NST Consultants, Inc.Completed
-
New York UniversityRecruitingMindfulness | Social Discrimination | Sexual and Gender MinoritiesUnited States